ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CELERINA GONZALEZ MD

1833 2ND AVE S - MAIL STOP 39300A RIVERWAY CLINIC - ANOKA

Anoka | Minnesota | 55303

(763) 587-4400

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 213 out of 1942

$421K Total Retail Price of All Prescriptions

Rank: 187 out of 1942

419 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 5,968 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 416 353 1 2
SIMVASTATIN 381 338 2 1
ATENOLOL 345 290 3 7
LEVOTHYROXINE SODIUM 332 289 4 3
OMEPRAZOLE 331 246 5 4
AMLODIPINE BESYLATE 248 233 6 6
HYDROCODONE-ACETAMINOPHEN 233 156 S3 7 12
ATORVASTATIN CALCIUM 220 176 8 14
HYDROCHLOROTHIAZIDE 194 184 9 8
METFORMIN HCL 173 147 10 10
METOPROLOL SUCCINATE 151 124 11 13
LOVASTATIN 130 99 12 32
ALENDRONATE SODIUM 129 94 13 21
CITALOPRAM HBR 121 73 14 15
RANITIDINE HCL 118 93 15 31
WARFARIN SODIUM 110 110 16 11
SERTRALINE HCL 108 103 17 20
FLUTICASONE PROPIONATE 108 71 17 37
TRAMADOL HCL 107 96 19 19
FUROSEMIDE 102 96 20 5
CRESTOR 98 82 21 34
GABAPENTIN 90 45 22 16
TRIAMTERENE-HCTZ 85 74 23 36
METOPROLOL TARTRATE 83 76 24 9
GLIMEPIRIDE 73 61 25 53
TRAZODONE HCL 72 58 26 24
METFORMIN HCL ER 67 31 27 46
POTASSIUM CHLORIDE 67 66 27 17
LIPITOR 65 55 29 147
FLUOXETINE HCL 65 48 29 45
PRAVASTATIN SODIUM 60 47 31 23
GEMFIBROZIL 58 45 32 60
CLONIDINE HCL 56 40 33 100
PANTOPRAZOLE SODIUM 55 34 34 48
LOSARTAN POTASSIUM 53 52 35 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.